NIDA RESEARCH CENTER GRANT PROGRAM GUIDELINES NIH Guide, Volume 25, Number 12, April 19, 1996 P.T. 04 Keywords: Drugs/Drug Abuse Grants Administration/Policy+ National Institute on Drug Abuse Review Procedures for NIDA Center Grant Applications The purpose of this notice is to inform the research community of the procedures the National Institute on Drug Abuse (NIDA) will follow in the review of center applications. See also NIDA Research Center Grant Program Guidelines, December 1995 and a subsequent amendment published in the NIH Guide, Vol. 25, No. 4, February 16, 1996. Duration of the review cycle: The review of center applications will consist of a three phase process, which will take two rounds of review to complete. Initially, an application will be reviewed by a center committee primarily for "centerness". This assessment will include considerations such as scientific significance, thematic integration, synergy of approach, extent of unique contributions, quality of leadership and other factors cited in the above mentioned guidelines. If the application does not meet the criteria for "centerness", the review will be concluded and the application will not be recommended for further consideration. If the application meets the "centerness" criteria, it will be further evaluated for its scientific merit by a group of appropriate substantive experts. The results of the scientific evaluation will be submitted to the center committee at their next regularly scheduled meeting. A final priority score, if appropriate, will be assigned by the center committee. Schedule for June 1 Applications: For applications submitted for the June 1, 1996 receipt date, the "centerness" review will be scheduled during the months of October or November. The scientific merit review will be completed at the February/March 1997 meeting of the center committee. Applications that are scored at this meeting will be presented to the May meeting of the NIDA Advisory Council. Schedule for October 1 Applications: For applications submitted for the October 1, 1996 receipt date, the "centerness" review will occur during the months of February or March 1997 followed by an evaluation of the scientific merit for successful applications and a subsequent final review by the center committee in June or July 1997. The scored applications will be presented to the September 1997 meeting of the NIDA Advisory Council. P20 and P30 Applications: For P20 and P30 applications, the process may be abbreviated depending upon the results of the initial review by the center committee. It is conceivable that an additional evaluation of scientific merit or a site visit by a separate panel of experts may not be necessary for some applications of limited scope and the center committee may be able to take final action within one round of review. Concurrent Submission of Center Components as R01 Applications: If components of a center application are concurrently submitted for review or submitted at another time such that the center application is either pending review or awaiting a funding decision, no final action will be taken on any scored component R01s until a final decision is made about the center application. INQUIRIES Office of Extramural Programs Research National Institute on Drug Abuse Parklawn Building, Room 10-42 Rockville, MD 20857 Telephone: (301) 443-2755 Email: jp862@nih.gov .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |